NVZMF OTC
Novozymes A/S
1W: -3.7%
1M: -8.4%
3M: +1.7%
YTD: +5.2%
1Y: +8.0%
3Y: +66.7%
5Y: -4.4%
$65.11
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$16.3B
+7.6% ▲
5Y CAGR: -4.4%
Total Liabilities
$5.5B
+36.7% ▲
5Y CAGR: -9.9%
Shareholders Equity
$10.9B
-2.9% ▼
5Y CAGR: -0.7%
Cash & Investments
$296M
+4.1% ▲
5Y CAGR: -25.6%
Total Debt
$22.4B
+1146.5% ▲
5Y CAGR: +42.8%
Net Debt
$22.1B
+1358.4% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $963M | $1.0B | $1.1B | $280M | $275M |
| Short-Term Investments | $75M | $80M | $40M | $4M | $20M |
| Cash & ST Investments | $1.0B | $1.1B | $1.2B | $284M | $296M |
| Net Receivables | $3.0B | $532M | $544M | $805M | $869M |
| Inventory | $3.0B | $3.8B | $3.6B | $721M | $772M |
| Other Current Assets | $880M | $618M | $947M | $70M | $46M |
| Total Current Assets | $7.8B | $9.2B | $9.5B | $1.9B | $2.0B |
| Property, Plant & Equip. | $10.2B | $12.1B | $12.3B | $3.0B | $3.0B |
| Goodwill & Intangibles | $5.0B | $4.7B | $4.5B | $10.0B | $11.1B |
| Long-Term Investments | -$16M | $235M | $227M | $39M | $276M |
| Other Non-Current Assets | $114M | $112M | $1.8B | $10M | -$239M |
| Total Non-Current Assets | $16.9B | $18.7B | $18.9B | $13.3B | $14.4B |
| Total Assets | $24.8B | $28.0B | $28.4B | $15.2B | $16.3B |
| — Liabilities — | |||||
| Accounts Payable | $1.5B | $1.9B | $1.6B | $423M | $421M |
| Short-Term Debt | $0 | $2.9B | $3.0B | $266M | $12.7B |
| Deferred Revenue | $163M | $138M | $0 | $0 | $0 |
| Other Current Liabilities | $3.2B | $1.4B | $1.7B | $338M | -$10.5B |
| Total Current Liabilities | $5.7B | $7.0B | $7.3B | $1.1B | $2.7B |
| Long-Term Debt | $0 | $3.6B | $4.3B | $1.5B | $0 |
| Other Non-Current Liab. | $6.5B | $148M | $2.4B | $40M | $1.4B |
| Total Non-Current Liabilities | $6.9B | $6.8B | $6.8B | $2.9B | $2.8B |
| Total Liabilities | $12.6B | $13.8B | $14.0B | $4.0B | $5.5B |
| — Equity — | |||||
| Common Stock | $564M | $562M | $75M | $126M | $126M |
| Retained Earnings | $11.3B | $13.1B | $13.8B | $11.0B | $11.2B |
| Accumulated OCI | -$40M | $213M | -$339M | $0 | $0 |
| Total Stockholders Equity | $11.8B | $13.8B | $14.0B | $11.2B | $10.9B |
| Total Liabilities & Equity | $24.8B | $28.0B | $28.4B | $15.2B | $16.3B |
| — Key Metrics — | |||||
| Total Debt | $482M | $919M | $7.7B | $1.8B | $22.4B |
| Net Debt | -$481M | $779M | $6.6B | $1.5B | $22.1B |
| Total Investments | $59M | $315M | $267M | $43M | $427M |